These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 17156824

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system.
    Eilertsen AL, Liestøl S, Mowinckel MC, Hemker HC, Sandset PM.
    Thromb Haemost; 2007 Jun; 97(6):938-43. PubMed ID: 17549295
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women.
    Keramaris NC, Christodoulakos GE, Lambrinoudaki IV, Dalamanga A, Alexandrou AP, Bramis J, Bastounis E, Creatsas GC.
    Climacteric; 2007 Oct; 10(5):400-7. PubMed ID: 17852143
    [Abstract] [Full Text] [Related]

  • 8. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Lambrinoudaki IV, Christodoulakos GE, Economou EV, Vlachou SA, Panoulis CP, Alexandrou AP, Kouskouni EE, Creatsas GC.
    Maturitas; 2008 Jan 20; 59(1):62-71. PubMed ID: 18164562
    [Abstract] [Full Text] [Related]

  • 9. Hormone therapy and raloxifene reduce the coagulation inhibitor potential.
    Andresen MS, Eilertsen AL, Abildgaard U, Sandset PM.
    Blood Coagul Fibrinolysis; 2007 Jul 20; 18(5):455-60. PubMed ID: 17581320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
    Hammar ML, van de Weijer P, Franke HR, Pornel B, von Mauw EM, Nijland EA, TOTAL Study Investigators Group.
    BJOG; 2007 Dec 20; 114(12):1522-9. PubMed ID: 17995496
    [Abstract] [Full Text] [Related]

  • 12. Significant differential effects of lower doses of hormone therapy or tibolone on markers of cardiovascular disease in post-menopausal women: a randomized, double-blind, crossover study.
    Koh KK, Han SH, Shin MS, Ahn JY, Lee Y, Shin EK.
    Eur Heart J; 2005 Jul 20; 26(14):1362-8. PubMed ID: 15872028
    [Abstract] [Full Text] [Related]

  • 13. Effect of different preparations of hormone therapy on lipid and glucose metabolism, coagulation factors, and bone mineral density in overweight and obese postmenopausal women.
    Osmanağaoğlu MA, Osmanağaoğlu S, Osmanağaoğlu T, Okumuş B, Bozkaya H.
    Fertil Steril; 2005 Aug 20; 84(2):384-93. PubMed ID: 16084879
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
    Mueck AO, Genazzani AR, Samsioe G, Vukovic-Wysocki I, Seeger H.
    Menopause; 2007 Aug 20; 14(6):978-84. PubMed ID: 17595593
    [Abstract] [Full Text] [Related]

  • 16. Effects of menopausal hormone therapy on hemostatic parameters, blood pressure, and body weight: open-label comparison of randomized treatment with estradiol plus drospirenone versus estradiol plus norethisterone acetate.
    Junge W, El-Samalouti V, Gerlinger C, Schaefers M.
    Eur J Obstet Gynecol Reprod Biol; 2009 Dec 20; 147(2):195-200. PubMed ID: 19879683
    [Abstract] [Full Text] [Related]

  • 17. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature.
    Cosman F, Baz-Hecht M, Cushman M, Vardy MD, Cruz JD, Nieves JW, Zion M, Lindsay R.
    Thromb Res; 2005 Dec 20; 116(1):1-13. PubMed ID: 15850603
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.